Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.30 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2201695 | 0.72 | TDP1 (0.36) | TDP1SIGMAR1TAAR1SLC6A2MAOA | |
| SCHEMBL3835921 | 0.72 | TDP1 (0.36) | TDP1SIGMAR1TAAR1SLC6A2MAOA | |
| Iodide SCHEMBL2874210 | 0.70 | TDP1 (0.35) | TDP1SIGMAR1TAAR1SLC6A2MAOA | |
| SCHEMBL688257 | 0.69 | TSHR (0.35) | LMNATSHRALOX12ACHE | |
| SCHEMBL28890989 | 0.69 | TSHR (0.35) | LMNATSHRALOX12ACHE | |
| SCHEMBL16188068 | 0.69 | SIGMAR1 (0.32) | SIGMAR1TAAR1SLC6A2MAOASLC6A4 | |
| SCHEMBL1726307 | 0.68 | ADRA2C (0.34) | TDP1LMNATSHRALOX12ADRA2A | |
| SCHEMBL22472085 | 0.68 | TRPA1 (0.37) | SIGMAR1TAAR1SLC6A2MAOASLC6A4 | |
| SCHEMBL2171435 | 0.68 | GABRA1 (0.37) | TDP1LMNATSHRALOX12ADRA2A | |
| SCHEMBL525224 | 0.67 | ALDH1A1 (0.35) | TDP1LMNATSHRALOX12ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011019-A | Green light luminescent material and preparation method and application thereof | 浙江大学温州研究院 | 2026-05-12 | — | — | CN | claimed |
| CN-119842046-A | Low-viscosity liquefied dicyandiamide latent curing agent, epoxy resin composition, and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-117903565-A | Halogen-free flame-retardant epoxy resin composition, cured product, prepreg and laminated board | 中国石油化工股份有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-116354865-A | Synthesis method of Pa Luo Weide intermediate | 成都百事兴科技实业有限公司 | 2023-06-30 | — | — | CN | claimed |
| CN-112876328-B | Method for asymmetric catalytic synthesis of gamma-cyano amide compound and chiral drug using compound | 四川大学 | 2022-02-08 | — | — | CN | claimed |
| CN-112876328-A | Method for asymmetric catalytic synthesis of gamma-cyano amide compound and chiral drug using compound | 四川大学 | 2021-06-01 | — | — | CN | claimed |
| CN-112471175-A | Preparation method of antibacterial and antiviral material, and product and application thereof | 上海纳米技术及应用国家工程研究中心有限公司 | 2021-03-12 | — | — | CN | claimed |
| CN-122011019-A | Green light luminescent material and preparation method and application thereof | 浙江大学温州研究院 | 2026-05-12 | — | — | CN | disclosed |
| CN-122011019-A | Green light luminescent material and preparation method and application thereof | 浙江大学温州研究院 | 2026-05-12 | — | — | CN | disclosed |
| CN-121466743-B | Method for recycling volatile organic compounds in waste gas | 厦门爱迪特环保科技有限公司 | 2026-04-03 | — | — | CN | disclosed |
| CN-121466743-A | Method for recycling volatile organic compounds in waste gas | 厦门爱迪特环保科技有限公司 | 2026-02-06 | — | — | CN | disclosed |
| US-20250214965-A1 | COMPOUND AS KIF18A INHIBITOR | HANGZHOU INNOGATE PHARMA CO., LTD. (CN) | 2025-07-03 | — | — | US | disclosed |
| CN-119462382-B | Polymerizable compound, liquid crystal composition comprising same and liquid crystal display device | 石家庄诚志永华显示材料有限公司 | 2025-05-13 | — | — | CN | disclosed |
| WO-2008101665-A1 | MACROCYCLIC COMPOUNDS AS HCV NS3 PROTEASE INHIBITORS | NOVARTIS AG (CH) | 2008-08-28 | — | — | WO | disclosed |
| US-20070286842-A1 | Organic Compounds and Their Uses | NOVARTIS AG (CH) | 2007-12-13 | — | — | US | disclosed |
| WO-2007133865-A2 | HCV/HIV INHIBITORS AN THEIR USES | NOVARTIS AG (CH) | 2007-11-22 | — | — | WO | disclosed |
| US-6872690-B2 | Herbicidal 2-alkynyl-pyri (mi) dines | WYETH (US) | 2005-03-29 | — | — | US | disclosed |
| US-20030073581-A1 | Herbicidal 2-alkynyl-pyri (mi) dines | WYETH | 2003-04-17 | — | — | US | disclosed |
| EP-1238586-A1 | Herbicidal 2-alkynyl-pyri(mi)dines | BASF AKTIENGESELLSCHAFT (DE) | 2002-09-11 | — | — | EP | disclosed |
| CN-1089614-A | Alpha-phosphonosulfonate squalene synthetase inhibitors and method | SQUIBB & SONS INC (US) | 1994-07-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030073581-A1 | Herbicidal 2-alkynyl-pyri (mi) dines | DDT, AOX1, RIOX2 | TDP1 983/4885SIGMAR1 970/4885TAAR1 1072/4885 |
| US-20070286842-A1 | Organic Compounds and Their Uses | OAT, OTC, AOX1 | TDP1 936/4885SIGMAR1 861/4885TAAR1 2592/4885 |
| US-20250214965-A1 | COMPOUND AS KIF18A INHIBITOR | KIF18A, KIF18B, KIF20A | TDP1 1572/4885SIGMAR1 4009/4885TAAR1 4352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.